Capital DailyCapital Daily
Markets · Investing · Business
Capital DailyCapital Daily
Finance

BillionToOne CEO Liquidates Entire Directly-Held Stake in the Company for $3 Million

The medical diagnostics company disclosed a substantial insider stock sale.

BillionToOne CEO Liquidates Entire Directly-Held Stake in the Company for $3 Million

Published September 17, 2026 · Category: Finance

Overview

Oguzhan Atay, Chairman and Chief Executive Officer of BillionToOne, Inc. (NASDAQ:BLLN), sold 30,331 shares of Class A Common Stock on September 14, 2026, for a total value of ~$3 million, as disclosed in a recent SEC Form 4 filing.

Transaction value based on SEC Form 4 weighted average sale price ($99.91); post-transaction value based on September 14, 2026 market close ($100.82).

Details

BillionToOne is a specialized diagnostics company with a market cap of $4.8 billion. The company's competitive advantage derives from its proprietary molecular counting platform, which enables precise quantification of individual DNA molecules to significantly enhance diagnostic accuracy.

Continue reading

Source

Originally published at www.fool.com.

Related Articles

CD
Capital Daily Newsroom

Capital Daily covers markets, crypto and commodities for Asia & the Middle East — tier-1 desk research, AI-driven analysis, institutional-grade data. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.